AGN News and Press, Allergan plc From 06/27/19

Hey everyone. Hope life has continued to treat you great. Today I am writing you in regard to the newest purchase in our dividend portfolio . I made the purchase on Friday and was thrilled with the buy, and then Tuesday came around and now I'm happy but also kind of questioning it. Things h...

Market Assessment Enanta ( ENTA ) is a small cap ($1.63B) biopharma with a focus on developing innovative therapeutics for viral infections and liver diseases. Enanta gained clinical and investor prominence with the approval of the HCV therapeutics, glecaprevir and paritaprevir, commercializ...

Yesterday, I wrote about the proposed Allergan ( AGN ) acquisition from the perspective of an Allergan shareholder. I got some questions coming from the perspective of the AbbVie ( ABBV ) shareholder, and today, I want to look at the transaction from that perspective. Because Allergan sharehol...

AbbVie promotes "collaboration spaces" (photo via AbbVie's Twitter account ). What Happens When A Hedged Stock Slips AbbVie ( ABBV ) was not one of Portfolio Armor's top names last month, but I included it in a hedged portfolio I presented then because it was a popular name among some...

PBF Energy (PBF), other names highlighted by our monitoring of insider activity: Marathon Petroleum (MPC) and Kinder Morgan (KMI). No one rational would credit insiders with mystical insight to foresee the demise of the largest refinery on the east coast. That the destruction and closing of ...

Today's top stories: Some good news for chipmakers; US futures on the rise; and China deal 90% complete. If you are interested in listening to Wall Street Breakfast to start your day, look for us in the following places: iTunes (find all Seeking Alpha Podcasts here ) Stitcher...

Bloomberg reports that AbbVie (NYSE: ABBV ) intends to syndicate a $38B 364-day bridge loan for its acquisition of Allergan (NYSE: AGN ). More news on: AbbVie Inc., Allergan plc, Healthcare stocks news, Merger & acquisition news, Read more ...

AbbVie ( ABBV ) has been under pressure for more than a year since it made an all-time high in January 2018. At the market close on Monday, before the market reaction on Tuesday from the announcement that ABBV was buying Allergan ( AGN ), ABBV was trading at $78 and change per share, a P...

Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha , iTunes , Stitcher and Spotify (click the highlighted links). Stronger-than-expected earnings from Micron Technologies (MU) helped boost investing sentiment overn...

Introduction I have held AbbVie ( ABBV ) since it was originally spun off from Abbott Labs. Moreover, I have been aggressively adding to my position for clients needing current income and dividend growth. All in all, it has been an excellent performer in spite of the fact that it is being ri...